Interacting selectively with the RNA element BRE (Bruno response element).

Catalysis of the transfer of an palmitoleyl group to a sulfur atom on the cysteine of a protein molecule.

Catalysis of the transfer of an acyl group to a sulfur atom on the cysteine of a protein molecule.

Catalysis of the reaction: S-adenosylmethioninamine + spermidine = 5'-methylthioadenosine + spermine.

Catalysis of the oxidative decarboxylation of malate with the concomitant production of pyruvate.

Catalysis of the reaction: solute(out) + Na+(out) = solute(in) + Na+(in).

dopamine receptor, adenylate cyclase activating pathway

dopamine receptor, adenylyl cyclase activating pathway

The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, followed by activation of adenylyl cyclase and a subsequent increase in the concentration of cyclic AMP.

transferase activity, transferring nitrogenous groups

Catalysis of the transfer of a nitrogenous group from one compound (donor) to another (acceptor).

Catalysis of the reaction: (S)-malate + NAD+ = pyruvate + CO2 + NADH + H+. Does not decarboxylate oxaloacetate.

G-protein signaling, adenylate cyclase inhibiting pathway

G-protein signalling, adenylyl cyclase inhibiting pathway

The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP.

malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity

Catalysis of the reaction: (S)-malate + NADP+ = pyruvate + CO2 + NADPH + H+. Also decarboxylates oxaloacetate.

negative regulation of adenylate cyclase activity

negative regulation of adenylyl cyclase activity

Any process that stops, prevents or reduces the rate of adenylate cyclase activity.

dopamine receptor, adenylate cyclase inhibiting pathway

dopamine receptor, adenylyl cyclase inhibiting pathway

The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, followed by inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP.